ARCHIVES

DCT Board Okays Contract Recompetitions, But Litton Bionetics May Be Barred From Two Supporting Gall’s Lab, Plus FCRF Program

This article is from The Cancer Letter archive.

Vol. 11 No. 41 | October 25, 1985

Download PDF Visit The Full Archive

Related Articles

In Brief: Paul Rambaut Leaving NCI For NATO Position; Niederhuber New Cancer Commission Chairman

December 9, 1988

New AIDs System For Classification Increase By 1% Cases Reported

August 1, 1986

Researcher Falsified EMF Data, ORI Says

July 30, 1999

IOM Report Urges DOD, VA, Congress To End Tobacco Use In Military.

July 10, 2009

Reagan Signs Appropriations Bill, Vetoes Biomedical Research Authorization Measure; Capitol Hill Angry

November 16, 1984

Concurrent Trastuzumab and Anthracyclines Not Necessary for High Pathological Response

November 29, 2013